Items tagged 'HFA & Foundation news'

Save the date!   We have two activities coming up for the bleeding disorders community in South Australia.     It…

Rare Disease Day is celebrated worldwide on 28 February 2021 to raise awareness about the experiences of people with rare diseases
Answers to FAQs about the COVID-19 vaccine for people with bleeding disorders
A new funding round for the HFA Research Fund is now open.
The HFA Council and Staff wish you a happy and safe festive season. The HFA office will close on Thursday 24 December 2020 and reopen on Monday 11 January 2021.
An update from HFA about the arrangements to access Hemlibra®, a treatment for haemophilia, and HFA’s ongoing work to advocate for new treatments.
We’re excited to kick off Bleeding Disorders Awareness Week today!. This week is an opportunity for individuals and families like you to take part in the campaign and get involved in activities to raise awareness about haemophilia, von Willebrand disease and related inherited bleeding disorders throughout Australia.
The National Blood Authority (NBA) released information today about the arrangements to add emicizumab (Hemlibra®) as a treatment for Australians on the National Product List.
The National Blood Authority (NBA) released information today about the arrangements to add emicizumab (Hemlibra®) as a treatment for Australians on the National Product List.
Emicizumab (Hemlibra®) will be publicy funded as a treatment for Australians with haemophilia

Join the HFA community

Sign up for the latest news, events and our free National Haemophilia magazine

Skip to content